# Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline

> **NCT03740672** · — · UNKNOWN · sponsor: **Lei Li** · enrollment: 1000 (estimated)

## Conditions studied

- Gynecologic Cancer
- Chemotherapy-induced Nausea and Vomiting

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03740672
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-22
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2018-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03740672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03740672, "Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03740672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*